Trials / Completed
CompletedNCT01115127
Myo-inositol and Melatonin in Pre-menopausal Women
Myo-inositol and Melatonin in Menopausal Transition. A Prospective, Randomized Trial
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- University of Messina · Academic / Other
- Sex
- Female
- Age
- 40 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether myo-inositol and melatonin, or myo-inositol alone, or melatonin alone, are effective in normalizing irregular bleeding and anovulatory cycles in pre-menopausal women.
Detailed description
Melatonin has produced a remarkable significant improvement of thyroid function, positive changes of gonadotropins towards reduced levels, and in some women a re-acquisition of normal menstrual cycle. Furthermore, an abrogation of menopause-related depression, amelioration of hot-flashes and improvement of quality and duration of sleep has been reported. Myo-inositol is involved in several aspects of human reproduction. Elevated concentrations of myo-inositol in human follicular fluids appear to play a positive function in follicular maturity and provide a marker of good quality oocytes. Nevertheless its positive role in PCOS women is a consequence of a defect in the insulin signalling pathway (inositol-containing phosphoglycan mediators) that seems to be primarily implicated in the pathogenesis of insulin resistance
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | melatonin | 30 subjects will take 1 tablet per day (at night-time) containing 3 grams of melatonin for 6 months |
| DIETARY_SUPPLEMENT | myo-inositol | 30 subjects will take 2 tablets per day containing 2 grams of myo-inositol, for 6 months. |
| DIETARY_SUPPLEMENT | melatonin plus myo-inositol | 30 subjects will take 2 grams per day of myo-inositol and 3 grams of melatonin at night-time for 6 months |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2010-05-04
- Last updated
- 2012-03-02
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01115127. Inclusion in this directory is not an endorsement.